GI
HELP

Gradient Investments’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Gradient Investments’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-84
Closed -$869 – 520
2024
Q2 		$869 Hold
84
– – ﹤0.01% 1097
2024
Q1 		$1.32K Hold
84
– – ﹤0.01% 875
2023
Q4 		$1.31K Hold
84
– – ﹤0.01% 1341
2023
Q3 		$1.7K Hold
84
– – ﹤0.01% 1217
2023
Q2 		$1.21K Hold
84
– – ﹤0.01% 1298
2023
Q1 		$1.23K Hold
84
– – ﹤0.01% 1173
2022
Q4 		$952 Buy
+84
New +$1.39K ﹤0.01% 1203

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Gradient Investments's HELP Position: Q3 2024 in Review

Gradient Investments sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 84 shares — an estimated $869 sold.

Gradient Investments first reported a position in HELP in Q4 2022 and held it in 7 quarters. The position peaked at $1.7K in Q3 2023. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Gradient Investments reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 84 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $869.
  • Gradient Investments first reported a position in Helus Pharma Inc. Common Stock in Q4 2022 and held it in 7 quarters.
  • Gradient Investments's Helus Pharma Inc. Common Stock position peaked at $1.7K in Q3 2023.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.